Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$13.78 - $18.84 $186,030 - $254,340
-13,500 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$10.5 - $20.2 $12,600 - $24,240
1,200 Added 9.76%
13,500 $163,000
Q3 2019

Nov 13, 2019

BUY
$20.27 - $28.93 $8,108 - $11,572
400 Added 3.36%
12,300 $292,000
Q2 2019

Aug 13, 2019

BUY
$22.36 - $30.41 $266,084 - $361,879
11,900 New
11,900 $345,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.62B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Brandywine Managers, LLC Portfolio

Follow Brandywine Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Managers, LLC with notifications on news.